Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 246

1.

Percutaneous closure of patent foramen ovale: success and outcomes of a low-volume procedure at a rural medical center.

Aslam F, Iliadis AE, Blankenship JC.

J Invasive Cardiol. 2007 Jan;19(1):20-4.

PMID:
17297180
[PubMed - indexed for MEDLINE]
2.

Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.

Silverman IE, Kiernan FJ, Kelsey AM, Brakoniecki JJ, Kazi FA, Dougherty JE, Boden WE, McKay RG.

Conn Med. 2003 Mar;67(3):135-44.

PMID:
12687787
[PubMed - indexed for MEDLINE]
3.

Patent foramen ovale closure in patients with transient ischemia attack/stroke.

Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schräder R, Spies H, Nowak B, Lissmann-Jensen H.

J Interv Cardiol. 2001 Apr;14(2):261-6.

PMID:
12053315
[PubMed - indexed for MEDLINE]
4.

[Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents].

Beitzke A, Schuchlenz H, Beitzke M, Gamillscheg A, Stein HI, Zartner P.

Z Kardiol. 2002 Sep;91(9):693-700. German.

PMID:
12448068
[PubMed - indexed for MEDLINE]
5.

Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.

Zajarias A, Thanigaraj S, Lasala J, Perez J.

J Invasive Cardiol. 2006 Nov;18(11):533-7.

PMID:
17090816
[PubMed - indexed for MEDLINE]
6.

Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).

Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Figulla HR.

Clin Res Cardiol. 2008 Dec;97(12):872-7. doi: 10.1007/s00392-008-0699-9. Epub 2008 Aug 11.

PMID:
18696022
[PubMed - indexed for MEDLINE]
7.

Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement.

Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P.

J Am Coll Cardiol. 2000 Apr;35(5):1311-6.

PMID:
10758974
[PubMed - indexed for MEDLINE]
Free Article
8.

Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B.

J Am Coll Cardiol. 2004 Aug 18;44(4):750-8.

PMID:
15312853
[PubMed - indexed for MEDLINE]
Free Article
9.

Transcatheter patent foramen ovale closure using the Premere PFO occlusion system.

Donti A, Giardini A, Salomone L, Formigari R, Picchio FM.

Catheter Cardiovasc Interv. 2006 Nov;68(5):736-40.

PMID:
17039524
[PubMed - indexed for MEDLINE]
10.

Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.

Butera G, Bini MR, Chessa M, Bedogni F, Onofri M, Carminati M.

Ital Heart J. 2001 Feb;2(2):115-8.

PMID:
11256538
[PubMed - indexed for MEDLINE]
11.

Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.

Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M.

Catheter Cardiovasc Interv. 2007 Sep;70(3):429-33.

PMID:
17722021
[PubMed - indexed for MEDLINE]
12.

Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.

Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.

Am J Cardiol. 2008 May 15;101(10):1487-92. doi: 10.1016/j.amjcard.2008.01.028. Epub 2008 Mar 17.

PMID:
18471463
[PubMed - indexed for MEDLINE]
13.

Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks.

Cujec B, Mainra R, Johnson DH.

Can J Cardiol. 1999 Jan;15(1):57-64.

PMID:
10024860
[PubMed - indexed for MEDLINE]
14.

Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.

Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N.

Catheter Cardiovasc Interv. 2006 Nov;68(5):741-6.

PMID:
17039525
[PubMed - indexed for MEDLINE]
15.

Five-year clinical and echocardiographic evaluation of the Das AngelWings atrial septal occluder.

Kay JD, O'Laughlin MP, Ito K, Wang A, Bashore TM, Harrison JK.

Am Heart J. 2004 Feb;147(2):361-8.

PMID:
14760337
[PubMed - indexed for MEDLINE]
16.

Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.

Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.

J Interv Cardiol. 2005 Jun;18(3):173-9.

PMID:
15966921
[PubMed - indexed for MEDLINE]
17.

Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients.

Onorato E, Melzi G, Casilli F, Pedon L, Rigatelli G, Carrozza A, Maiolino P, Zanchetta M, Morandi E, Angeli S, Anzola GP.

J Interv Cardiol. 2003 Feb;16(1):43-50.

PMID:
12664817
[PubMed - indexed for MEDLINE]
18.

Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.

Shafi NA, McKay RG, Kiernan FJ, Silverman IE, Ahlquist M, Silverman DI.

Int J Cardiol. 2009 Nov 12;137(3):314-6. doi: 10.1016/j.ijcard.2009.06.045. Epub 2009 Jul 17.

PMID:
19616327
[PubMed - indexed for MEDLINE]
19.

Percutaneous closure of patent foramen ovale: a case series and literature review.

Mareedu RK, Shah MS, Mesa JE, McCauley CS.

Clin Med Res. 2007 Dec;5(4):218-26. Epub 2007 Dec 17. Review.

PMID:
18086906
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Five-year experience with percutaneous closure of patent foramen ovale.

Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Liebeskind DS.

Am J Cardiol. 2007 May 1;99(9):1316-20. Epub 2007 Mar 20.

PMID:
17478165
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk